Product Information
OXCARBAZEPINE 300 MG/5 ML SUSP is a generic product labeled by NorthStar Rx LLC, priced at $0.1168 per ML under NDC 72603025201. Its NADAC has been published 94 times since Nov 6, 2024.
FDA first approved this application on Oct 20, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/mL
Manufacturer
NorthStar Rx LLCNDC
72603025201
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA216749FDA Approved
10/20/2023
TE Code
AB
On Market Since
5/1/2024
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has been published 94 times since Nov 6, 2024, and over the history we have for it it has declined 56.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1168 per ML |
|---|---|
| All-time high | $0.2687 (Nov 13, 2024) |
| All-time low | $0.1168 (Aug 19, 2026) |
| 52-week high | $0.1754 |
| 52-week low | $0.1168 |
| Median price | $0.1664 |
| Average price | $0.1797 |
| Largest weekly change | -18.4% (Nov 20, 2024) |
| Weeks tracked | 94 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE 300 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG/5 ML SUSP, manufactured by NorthStar Rx LLC, is $0.1168 per ML (NDC 72603025201), effective Aug 19, 2026.
How has the price of OXCARBAZEPINE 300 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has declined 56.6%. It has been tracked across 94 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG/5 ML SUSP?
Since Nov 6, 2024, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has ranged from a low of $0.1168 (Aug 19, 2026) to a high of $0.2687 (Nov 13, 2024), with a median of $0.1664 per ML.
Are there cheaper alternatives to OXCARBAZEPINE 300 MG/5 ML SUSP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXCARBAZEPINE 300 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures OXCARBAZEPINE 300 MG/5 ML SUSP?
OXCARBAZEPINE 300 MG/5 ML SUSP (NDC 72603025201) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.